Description

BSE permits trading in Rights Entitlements (REs) for renunciation of Healthcare Global Enterprises Limited from March 11 to March 20, 2026, with the rights issue open until March 25, 2026.

Summary

BSE has permitted dealings in Rights Entitlements (REs) for renunciation of Healthcare Global Enterprises Limited (Scrip Code: 751095, Scrip ID: HCG-RE) effective Wednesday, March 11, 2026. The REs are tradable on a T+1 rolling settlement basis on a trade-for-trade settlement model, in dematerialized form only.

Key Points

  • Rights Entitlements (REs) for Healthcare Global Enterprises Limited are tradable on BSE from March 11 to March 20, 2026
  • Scrip Code: 751095 | Scrip ID: HCG-RE | ISIN: INE075I20017
  • Market Lot: 1 | Group: R
  • Settlement: T+1 Rolling Settlement on trade-for-trade basis
  • REs are tradable in dematerialized form only
  • Trading members must inform clients about the commencement of RE trading and include the ISIN
  • REs must not be mistaken for ordinary shares of the company
  • Contract notes/bills must carry a prominent disclaimer about the nature of REs

Regulatory Changes

No new regulatory changes. This notice is issued under the framework established by notice no. 20200305-21 dated March 05, 2020 and notice no. 20200518-34 dated May 18, 2020 governing Rights Entitlements trading.

Compliance Requirements

  • Trading members must notify all clients about the commencement of RE trading, specifying the ISIN (INE075I20017)
  • Trading members must clarify that REs are not ordinary shares of the company
  • Contract notes and bills for RE purchases must prominently display a disclaimer stating that purchasing REs only entitles the holder to participate in the rights issue or renounce before the issue closes
  • Unsettled REs (neither subscribed nor renounced) will lapse and be extinguished after the Issue Closing Date (March 25, 2026)

Important Dates

  • March 11, 2026: Commencement of RE trading and Rights Issue opening date
  • March 20, 2026: Last date for trading in Rights Entitlements (renunciation window closes)
  • March 25, 2026: Rights Issue closing date; unexercised and unrenounced REs lapse after this date

Impact Assessment

This notice affects existing shareholders of Healthcare Global Enterprises Limited who have been allotted Rights Entitlements and trading members facilitating transactions. Shareholders can either subscribe to the rights issue, renounce their REs by selling them on the exchange between March 11–20, or let them lapse. The trade-for-trade settlement and T+1 basis reduces counterparty risk. The impact is moderate, confined to participants in the rights issue and those trading HCG-RE on BSE.

Impact Justification

Routine rights entitlement trading notice affecting existing shareholders and trading members of Healthcare Global Enterprises Limited; impacts those participating in or renouncing the rights issue.